GlassScriptPhysician profile
Ashley K Bruce
NPI 1740237932
$6,845.99
in general payments reported to CMS, 2019-2025
52 companies · $1,491 in 2025
The $1,491 reported for 2025 was more than what 92% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,141 · 2022: $1,155 · 2023: $1,458 · 2024: $1,600 · 2025: $1,491.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,525 · Education: $25.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,524.87 |
| Education | $25.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,212.25 | 2021-2025 | |
| Novo Nordisk INC | $879.95 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Abbott Laboratories | $494.27 | 2022-2025 | Freestyle Libre 3 |
| Amgen INC. | $454.38 | 2021-2025 | Repatha, Otezla, Evenity |
| Pfizer INC. | $448.32 | 2021-2025 | |
| Astrazeneca Pharmaceuticals LP | $372.64 | 2021-2025 | Airsupra, Farxiga, Breztri |
| Lilly USA, LLC | $246.15 | 2021-2025 | Mounjaro, Zepbound |
| Glaxosmithkline, LLC. | $225.22 | 2021-2025 | Shingrix, Arexvy, Bexsero |
| Otsuka America Pharmaceutical, INC. | $224.70 | 2023-2025 | Rexulti |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $220.56 | 2022-2025 | Caplyta |
| Lundbeck LLC | $160.62 | 2023-2025 | Rexulti, Vyepti |
| Merck Sharp & Dohme LLC | $128.60 | 2021-2024 | Gardasil, Gardasil 9, Capvaxive |
| Viiv Healthcare Company | $118.87 | 2023-2025 | Apretude, Cabenuva |
| Amarin Pharma, INC. | $99.35 | 2021-2023 | |
| Takeda Pharmaceuticals U.S.A., INC. | $88.08 | 2021-2022 |
Show all 52 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axsome Therapeutics, INC. | $86.80 | 2024-2025 | Symbravo, Auvelity |
| E.R. Squibb & Sons, L.L.C. | $84.63 | 2022-2024 | Camzyos, Eliquis |
| Astellas Pharma US INC | $84.59 | 2021-2025 | Veozah, Myrbetriq |
| Boehringer Ingelheim Pharmaceuticals, INC. | $83.46 | 2021-2025 | Jardiance |
| Sanofi-Aventis U.S. LLC | $79.25 | 2021-2025 | |
| Boston Scientific Corporation | $71.69 | 2023-2025 | General - Male Sui |
| Vanda Pharmaceuticals INC. | $66.98 | 2025 | Hetlioz, Fanapt |
| Theratechnologies INC. | $66.57 | 2025 | Trogarzo, Egrifta |
| Novartis Pharmaceuticals Corporation | $57.29 | 2021-2023 | |
| Kowa Pharmaceuticals America, INC. | $55.42 | 2021-2025 | Zoryve |
| Antares Pharma, INC. | $48.74 | 2022-2023 | Xyosted, Tlando, Nocdurna |
| Teva Pharmaceuticals USA, INC. | $46.57 | 2021 | |
| Horizon Therapeutics Plc | $43.45 | 2021-2022 | |
| Janssen Pharmaceuticals, INC | $43.45 | 2023-2024 | Spravato |
| Jazz Pharmaceuticals INC. | $40.11 | 2021 | |
| Nevro Corp. | $36.12 | 2022-2023 | Senza |
| Bayer Healthcare Pharmaceuticals INC. | $35.92 | 2021-2024 | |
| Esperion Therapeutics, INC. | $34.59 | 2021-2025 | Nexletol |
| Biohaven Pharmaceutical Holding Company LTD. | $33.44 | 2022 | |
| Exact Sciences Corporation | $31.77 | 2025 | Cologuard Collection Kit |
| Dexcom, INC. | $29.91 | 2022-2023 | Dexcom G6 Transmitter |
| Shield Therapeutics INC | $27.34 | 2024 | |
| Currax Pharmaceuticals LLC | $25.00 | 2023 | Nexletol |
| Dynavax Technologies Corporation | $24.19 | 2023-2024 | Heplisav-B |
| Tris Pharma INC | $22.09 | 2023 | Dyanavel Xr |
| Verona Pharma, INC. | $20.28 | 2025 | Ohtuvayre |
| Seqirus USA INC | $19.96 | 2021 | |
| Arbor Pharmaceuticals, INC. | $19.83 | 2021 | |
| Philips North America LLC | $19.59 | 2024 | (Ck7) Extended Holter |
| Inogen, INC. | $19.38 | 2022-2023 | Inogen One G5 Oxygen Concentrator - Bluetooth, Inogen One G3 Oxygen Concentrator |
| Kyowa Kirin, INC. | $18.79 | 2024 | Crysvita |
| Azurity Pharmaceuticals, INC. | $18.69 | 2024 | Edarbi |
| Supernus Pharmaceuticals, INC. | $16.66 | 2022 | Xyosted |
| Halozyme INC | $16.24 | 2023 | |
| Vbi Vaccine (Delaware) INC. | $14.85 | 2023 | Prehevbrio |
| Medtronic, INC. | $14.59 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $13.80 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashley Bruce listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.